186 related articles for article (PubMed ID: 23200265)
1. A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure.
Takagi H; Mizuno Y; Goto SN; Umemoto T;
Int J Cardiol; 2013 Sep; 167(6):3062-5. PubMed ID: 23200265
[No Abstract] [Full Text] [Related]
2. Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review.
Lacourcière Y
Clin Exp Hypertens; 2013; 35(1):50-60. PubMed ID: 22866964
[TBL] [Abstract][Full Text] [Related]
3. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
[TBL] [Abstract][Full Text] [Related]
4. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
6. The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: the SURGE 2 practice-based study.
Redon J; Bilo G; Parati G;
Blood Press; 2013 Dec; 22(6):377-85. PubMed ID: 23957824
[TBL] [Abstract][Full Text] [Related]
7. An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors.
Kjeldsen S; Mancia G; Schmieder R; Mattheus M; Unger T
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):673-82. PubMed ID: 23750676
[TBL] [Abstract][Full Text] [Related]
8. Overview of telmisartan for blood pressure reduction among angiotensin II receptor blockers: a meta-analysis of head-to-head randomized trials.
Takagi H; Mizuno Y; Goto SN; Umemoto T;
Int J Cardiol; 2013 Sep; 167(6):3051-6. PubMed ID: 23219133
[No Abstract] [Full Text] [Related]
9. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
[TBL] [Abstract][Full Text] [Related]
10. Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension.
Minami J; Furukata S; Ishimitsu T; Matsuoka H
Int Heart J; 2009 Jan; 50(1):85-93. PubMed ID: 19246849
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension.
Kjeldsen SE; Schmieder RE; Unger T; Mancia G
Curr Med Res Opin; 2010 Apr; 26(4):879-87. PubMed ID: 20144138
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan induced urticarial vasculitis.
Mahajan VK; Singh R; Gupta M; Raina R
Indian J Pharmacol; 2015; 47(5):560-2. PubMed ID: 26600649
[TBL] [Abstract][Full Text] [Related]
14. Results of increasing doses of hydrochlorothiazide in combination with an angiotensin receptor blocker in patients with uncontrolled hypertension.
Neldam S; Edwards C;
J Clin Hypertens (Greenwich); 2008 Aug; 10(8):612-8. PubMed ID: 18772643
[TBL] [Abstract][Full Text] [Related]
15. The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
Vogt L; Navis G; Köster J; Manolis AJ; Reid JL; de Zeeuw D;
J Hypertens; 2005 Nov; 23(11):2055-61. PubMed ID: 16208149
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
Neldam S; Schumacher H; Guthrie R
Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
[TBL] [Abstract][Full Text] [Related]
18. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A
J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
[TBL] [Abstract][Full Text] [Related]
19. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
White WB; Davidai G; Schumacher H
J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and improving endothelial dysfunction in hypertensive patients.
Hu ZP; Wang BN; Qian HY; Zhou Q; Wei W; Wang Y
Int Heart J; 2010 Jul; 51(4):252-8. PubMed ID: 20716842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
